Ai întrebări despre autism, ADHD, anxietate sau depresie? Găsești ghiduri clare, verificate de specialiști. Acum, acces gratuit.
This narrative review examines how precise phenotypic characterization of treatment-resistant depression (TRD) can improve clinical outcomes and guide therapeutic interventions. The authors analyze current definitional frameworks and evidence-based approaches to identifying and managing patients with depression that has not responded to standard pharmacological treatments.
This article examines how neuroinflammation contributes to depression through activation of immune pathways and cytokine signaling in the brain. It discusses identified biomarkers of neuroinflammation and explores anti-inflammatory therapeutic approaches as potential treatments for depressive disorders.
This study protocol examines gut microbiota composition differences between Malaysian patients with major depressive disorder (in monotherapy and polypharmacy groups) and healthy controls using 16S rRNA gene sequencing. The research aims to fill knowledge gaps about how microbial metabolites influence mood and behavior in the Malaysian population.
This health services research study analyzed treatment patterns, healthcare utilization, and costs among commercially insured US patients with newly diagnosed major depressive disorder, comparing pharmacologic, nonpharmacologic, combination, and no treatment approaches. The study examined associations between patient/provider characteristics and treatment selection while measuring healthcare resource use and economic outcomes over a 2-year follow-up period.
This study uses MRI to investigate structural brain changes associated with major depressive disorder, examining cortical thinning patterns across brain regions. The research contributes to understanding the neurobiological mechanisms underlying depression, moving beyond symptom description toward identifying neural signatures of the condition.
